<DOC>
	<DOCNO>NCT01692457</DOCNO>
	<brief_summary>The purpose study assess safety effectiveness golimumab treatment rheumatoid arthritis , psoriatic arthritis ankylose spondylitis among Filipino patient .</brief_summary>
	<brief_title>A Study Assess Safety Effectiveness Golimumab Filipino Patients With Rheumatoid Arthritis , Psoriatic Arthritis Ankylosing Spondylitis</brief_title>
	<detailed_description>This open-label ( people know identity intervention ) , multi-center ( study conduct multiple site ) , observational study ( study investigators/ physician observe patient measure outcome ) evaluate safety effectiveness golimumab treatment rheumatoid arthritis , psoriatic arthritis ankylose spondylitis among Filipino patient . The study enroll approximately 50 patient would use golimumab dose regimen stipulate product insert . As observational study , assessment patient base accepted clinical practice Philippines . Patients monitor baseline every 4 week thereafter period 24 week . Safety evaluation adverse event , clinical laboratory test , physical examination , concomitant medication , co-morbid condition monitor throughout study . The total study conduct 3 year duration treatment 24 week .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Have rheumatoid arthritis exhibit least four follow criterion : morning stiffness least one hour present least six week , swell three joint least six week , swell wrist , metacarpophalangeal proximal interphalangeal joint six week , symmetrical joint swelling , Xray change hand include erosion unequivocal bony decalcification , rheumatoid nodule , serum rheumatoid factor method positive less 5 percent normal Have ankylose spondylitis must either follow : Grade 34 sacroiliitis least one clinical criterion , Grade 34 unilateral sacroiliitis , Grade 2 bilateral sacroiliitis clinical criterion 1 ( limitation motion lumbar spine 3 plane : anterior flexion , lateral flexion , extension ) criterion 2 ( history pain lumbar spine dorsolumbar junction ) criterion 3 ( limited chest expansion 2.5 cm less , measure fourth intercostal line ) Have psoriatic arthritis include 3 follow condition : inflammatory arthritis ( peripheral arthritis and/or sacroiliitis spondylitis ) , presence psoriasis , ( usual ) absence serological test rheumatoid factor Known hypersensitivity golimumab component agent preparation Pregnant breastfeeding female Not agree protocoldefined use effective contraception Patients receive live vaccine treatment Patients document clinically important , active infection ( eg , active tuberculosis infection ) Patients document past current history malignancy significant cytopenia ( reduction number blood cell )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Psoriatic Arthritis</keyword>
	<keyword>Ankylosing Spondylitis</keyword>
	<keyword>Arthritis</keyword>
	<keyword>Spondylitis</keyword>
	<keyword>Joint pain</keyword>
	<keyword>CNTO148</keyword>
	<keyword>Golimumab</keyword>
	<keyword>Simponi</keyword>
	<keyword>Filipino</keyword>
	<keyword>Post-Marketing</keyword>
	<keyword>Surveillance</keyword>
</DOC>